| Richard V Benya, | |
|
1740 W Taylor St, Chicago, IL 60612-7232 | |
| (866) 600-2273 | |
| Not Available |
| Full Name | Richard V Benya |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1740 W Taylor St, Chicago, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568567998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036-078274 (Illinois) | Primary |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
People who suffer from dementia and those that care for them, say they are fighting a constant battle to receive proper information about their condition and its treatment according to new research launched today at the British Pharmaceutical Conference in Manchester.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer - the second-leading cause of cancer-related deaths in the U.S.
Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today that it intends to commence a private placement of $280 million in aggregate principal amount of senior secured notes due 2017. The net proceeds of the Offering will be used to repay all of the outstanding indebtedness under the company's existing senior secured term loan and asset-based revolving credit facility, to repay certain other indebtedness and to pay related fees and expenses.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard V Benya, 909 S Wolcott Ave, 5135 Comrb, Mc 716, Chicago, IL 60612-3725 Ph: (312) 413-0395 | Richard V Benya, 1740 W Taylor St, Chicago, IL 60612-7232 Ph: (866) 600-2273 |
News Archive
People who suffer from dementia and those that care for them, say they are fighting a constant battle to receive proper information about their condition and its treatment according to new research launched today at the British Pharmaceutical Conference in Manchester.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
A study recently published in the journal Carcinogenesis by researchers at the University of Kansas shows a new role for the protein adenomatous polyposis coli (APC) in suppressing colorectal cancer - the second-leading cause of cancer-related deaths in the U.S.
Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today that it intends to commence a private placement of $280 million in aggregate principal amount of senior secured notes due 2017. The net proceeds of the Offering will be used to repay all of the outstanding indebtedness under the company's existing senior secured term loan and asset-based revolving credit facility, to repay certain other indebtedness and to pay related fees and expenses.
› Verified 7 days ago
Dr. Sorin C Danciu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |